Proteomic and genomic biomarkers for age-related macular degeneration

Advances in Experimental Medicine and Biology

Volumn 664, Issue , 2010, Pages 411-417

  Gu, Jiayin ^b   Pauer, Gayle J T ^b   Yue, Xiuzhen ^b   Narendra, Umadevi ^b   Sturgill, Gwen M ^b   Bena, James ^b   Gu, Xiaorong ^b   Peachey, Neal S ^b   Salomon, Robert G ^b   Hagstrom, Stephanie A ^b   Crabb, John W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CARBOXYETHYLPYRROLE; CARBOXYETHYLPYRROLE ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; PROTEIN ARMS2; PROTEIN HTRA1; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ALLELE; ARMS2 GENE; CFH GENE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOMICS; GENOTYPE; HETEROZYGOTE; HTRA1 GENE; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; BIOLOGICAL MARKERS; GENOTYPE; HUMANS; MACULAR DEGENERATION; PROTEOMICS; PYRROLES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 79957612084     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1399-9_47     Document Type: Conference Paper

References (26)

1. Age-Related Eye Disease Study Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamine C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417-1436
2. Crabb JW, Miyagi M, Gu X et al (2002) Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99:14682-14687 (Pubitemid 35334544)
3. Dewan A, Liu M, Hartman S et al (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314:989-992 (Pubitemid 44749943)
4. Ebrahem Q, Renganathan K, Sears J et al (2006) Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc Natl Acad Sci U S A 103:13480-13484 (Pubitemid 44380133)
5. Edwards AO, Ritter R 3rd, Abel KJ et al (2005) Complement factor H polymorphism and agerelated macular degeneration. Science 308:421-424 (Pubitemid 40530082)
6. Fliesler SJ, Anderson RE (1983) Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 22:79-131
7. Fritsche LG, Loenhardt T, Janssen A et al (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40:892-896 (Pubitemid 351913654)
8. Gu X, Meer SG, Miyagi M et al (2003a) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278:42027-42035 (Pubitemid 37310467)
9. Gu J, Pauer GJT, Yue X et al (2009) Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics PMID: 19202148
10. Gu X, Renganathan K, Grimm C et al (2004) Rapid changes in retinal oxidative protein modifications induced by blue light. Invest Ophthalmol Vis Sci 45:E-abstract 3474
11. Gu X, Sun M, Gugiu B et al (2003b) Oxidatively truncated docosahexaenoate phospholipids: Total synthesis, generation, and peptide adduction chemistry. J Org Chem 68:3749-3761 (Pubitemid 36576624)
12. Hageman GS, Anderson DH, Johnson LV et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227-7232 (Pubitemid 40696361)
13. Haines JL, Hauser MA, Schmidt S et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-421 (Pubitemid 40530081)
14. Handa JT, Verzijl N, Matsunaga H (1999) Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 40:775-779 (Pubitemid 29109458)
15. Hollyfield JG, Bonilha VL, Rayborn ME et al (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14:194-198 (Pubitemid 351214555)
16. Ishibashi T, Murata T, Hangai M et al (1998) Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol 116:1629-1632 (Pubitemid 29001961)
17. Jakobsdottir J, Conley YP,Weeks DE et al (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77:389-407 (Pubitemid 41192646)
18. Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389 (Pubitemid 40530070)
19. Maller JB, Fagerness JA, Reynolds RC et al (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39:1200-1201 (Pubitemid 47482689)
20. Maller J, George S, Purcell S et al (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38:1055-1059 (Pubitemid 44325932)
21. Ng KP, Gugiu B, Renganathan K et al (2008) Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics 7:1397-1405 (Pubitemid 352038281)
22. Renganathan K, Ebrahem Q, Vasanji A et al (2008) Carboxyethylpyrrole adducts, age-related macular degeneration and neovascularization. Adv Exp Med Biol 613:261-267
23. Renganathan K, Sun M, Darrow R et al (2003) Light induced protein modifications and lipid oxidation products in rat retina. Invest Ophthalmol Vis Sci 44:E-abstract 5129
24. Rivera A, Fisher SA, Fritsche LG et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14:3227-3236 (Pubitemid 41631297)
25. Yang Z, Camp NJ, Sun H (2006) A variant of the HTRA1 gene increases susceptibility to agerelated macular degeneration. Science 314:992-993 (Pubitemid 44749944)
26. Yates JR, Sepp T, Matharu BK et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357:553-561 (Pubitemid 47236280)